Search results for "Highlights"
SGLT-2 inhibitors linked to lower risk of cardiac events compared with DPP-4 inhibitors
A retrospective study of Canadian and British patients with type 2 diabetes found lower rates of cardiovascular death among those taking sodium-glucose cotransporter-2 (SGLT-2) inhibitors than in matched patients who took dipeptidyl peptidase-4 (DPP-4) inhibitors.
https://diabetes.acponline.org/archives/2020/10/09/1.htm
9 Oct 2020
Among older adults with type 2 diabetes, insulin use most prevalent in those with poor health
In a longitudinal study of 21,531 patients, those in poor or intermediate health at age 75 years were more likely to use insulin than those in good health (29.4% and 27.5% versus 10.5%, respectively) and less likely to discontinue it during follow-up.
https://diabetes.acponline.org/archives/2019/10/11/3.htm
11 Oct 2019
New guideline from Endocrine Society offers guidance on lipid management
The guideline includes recommendations on the use of statins and lipid testing in type 1 and 2 diabetes, as well as other endocrine-related diseases and conditions.
https://diabetes.acponline.org/archives/2020/11/13/1.htm
13 Nov 2020
Different diabetes phenotypes associated with varying prevalence of complications
Patients were categorized into five groups: mild age-related diabetes, mild obesity-related diabetes, severe autoimmune diabetes, severe insulin-resistant diabetes, and severe insulin-deficient diabetes.
https://diabetes.acponline.org/archives/2019/08/09/3.htm
9 Aug 2019
CGM improved glycemic control in type 1 diabetes with or without pump
Real-time continuous glucose monitoring (CGM), with either an insulin pump or multiple daily injections, was associated with sustained improvements in HbA1c levels compared to self-monitoring of blood glucose, according to a small randomized trial.
https://diabetes.acponline.org/archives/2019/10/11/2.htm
11 Oct 2019
Weight loss through gastric bypass or diet improved insulin sensitivity in patients with type 2 diabetes
Results from this small study suggest that reducing adipose tissue volume, by whatever means, will improve blood glucose control in patients with type 2 diabetes, an accompanying editorial noted.
https://diabetes.acponline.org/archives/2020/09/11/1.htm
11 Sep 2020
Metabolic surgery associated with lower risk for MACE in obese adults with type 2 diabetes
Patients with diabetes and obesity who had metabolic surgery were matched in a 1:5 ratio to those who received usual care, with incidence of a major cardiovascular event (MACE) as the primary outcome.
https://diabetes.acponline.org/archives/2019/09/13/3.htm
13 Sep 2019
Cardiology guidance supports use of SGLT-2 inhibitors, GLP-1 receptor agonists for CV benefits in diabetes
Evidence on sodium-glucose cotransporter-2 (SGLT-2) inhibitors and glucagon-like peptide-1 (GLP-1) receptor agonists indicates that these drugs can be used not just for glucose control but for cardiovascular (CV) risk reduction in patients with type 2 diabetes, according to a new expert pathway.
https://diabetes.acponline.org/archives/2020/08/14/1.htm
14 Aug 2020
AHA offers new guidance on treating diabetes and heart failure
A scientific statement from the American Heart Association and the Heart Failure Society of America describes new approaches to medications, lifestyles, and the importance of multidisciplinary care that includes physicians and other clinicians.
https://diabetes.acponline.org/archives/2019/06/14/3.htm
14 Jun 2019
ADA updates standards of care related to CV, renal health in type 2 diabetes
The updates were based on findings from the industry-funded CREDENCE (Canagliflozin and Renal Outcomes in Type 2 Diabetes and Nephropathy) trial.
https://diabetes.acponline.org/archives/2019/06/14/2.htm
14 Jun 2019